ウェビナーアーカイブ
- ホーム
- ウェビナーアーカイブ
-
パネルディスカッション：診断薬開発者がIVDRを理解するために知っておくべきこと
What Diagnostics Developers Need to Know About Navigating the IVDR
4人の専門家が、IVDRの下で診断薬開発者が成功するために知っておくべきことについて議論します。（英語）
1. Caroline Alexander:2. Sascha Wettmarshausen, 3. Ilinica Visanoiu, 4. Tracey Lomax
1. Director of QA/RA at Genedrive.
2. Head of regulatory affairs at VDGH.
3. Regulatory affairs manager at MRC Holland.
4. Chief quality and regulatory officer at Global Access Diagnostics. -
８月７日（木 14:00 ：ウイルスベクター製造におけるEndoCleave エンドヌクレアーゼの性能評価 収率・品質・価値の総合的検討
-
パネルディスカッション：スケーラブルでコスト効率の高い技術によるアデノ随伴ウイルス（AAV）生産の効率化
Michael DiBiasio-White※1, Ying Cai, PhD※2, Roland Pach, PhD※3
※1 Head of Process Development and Manufacturing Innovations, Affinia Therapeutics
※2 Executive Director, Manufacturing Science and Technology, Ultragenyx Therapeutics
※3 Global Analytical Expert, CMC, CGT, & Alternative Formats, Roche -
パネルディスカッション： Current & Future Realities of mRNA Process Development
Jeff Atkinson, Ph.D.※1, James Nolan※2, Khaled Yamout※3
※1 Vice President, Technical Operations, Omega Therapeutics
※2 Vice President, Head of Technical Operations, Sail Biomedicines
※3 Analytical Sciences, Quality, Development & Manufacturing, Consultant -
「細胞療法および移植のための最大限の安全性と治療効果を発揮する強力なツール」
Powerful tools for maximum safety and curative cell for cell therapy and transplant
Prof. Shusen Wang※1, Dr. Gumpei Yoshimatsu※2, Prof. Po-Wei Lee※3
※1 Director of Cell Transplant Department, Tianjin First Central Hospital, China
※2 MD, PhD, Director for Regenerative Center, Associate Professor, Fukuoka University, Japan
※3 Director, BioGend Therapeutics, Taiwan -
パネルディスカッション：Opening the “Black Box” of the mRNA regulatory paradigm
Melanie Cerullo※1, Oreanna Thomas※2, Ye Zhang※3,
※1 Chief Quality & Regulatory Officer, ReciBioPharm
※2 Associate Director, Nutcracker Therapeutics
※3 Chief Regulatory Officer, Arcturus Therapeutics -
Evaluation of current & advanced analytical technologies for the comprehensive characterization of mRNA and its impurities
Axel Guilbaud
Principal Scientist, Genentech
-
The Current State of Molecular Diagnostics for Respiratory Infections (Free virtual roundtable)
-
Exploring the Molecular Diagnostics with RNA enzymes
Dr. JinSeok Kang※1, Ms. Teoh Hui Kee※2
※1 CEO, Co-founder, iGENETECH, Republic of Korea
※2 Laboratory Manager, Vivantis Technologies, Malaysia -
Important Decisions for mRNA Vaccines and Therapeutics Development
Dr. Piao Xijun※1, Dr. Rena Akahori※2
※1 Vice President, Head of mRNA Process Development, CATUG Biotechnology, China
※2 Scientist, CMC Development Group, ARCALIS INC, Japan